Cancer Immunology and Immunotherapy

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Specialties, Oncology
Cover of the book Cancer Immunology and Immunotherapy by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642141362
Publisher: Springer Berlin Heidelberg Publication: April 11, 2011
Imprint: Springer Language: English
Author:
ISBN: 9783642141362
Publisher: Springer Berlin Heidelberg
Publication: April 11, 2011
Imprint: Springer
Language: English

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

More books from Springer Berlin Heidelberg

Cover of the book Environmental Photochemistry Part III by
Cover of the book Anterior Ischemic Optic Neuropathy by
Cover of the book Digestive System by
Cover of the book Basics of Acupuncture by
Cover of the book Homo Sapiens Digitalis - Virtuelle Ergonomie und digitale Menschmodelle by
Cover of the book Zweihundert Jahre Entwicklung der Theoretischen Chemie im deutschsprachigen Raum by
Cover of the book The Sun: New Challenges by
Cover of the book The Paraganglia by
Cover of the book Glass Transition, Dynamics and Heterogeneity of Polymer Thin Films by
Cover of the book Preoperative (Neoadjuvant) Chemotherapy by
Cover of the book Modern Theories of Many-Particle Systems in Condensed Matter Physics by
Cover of the book Fluid Dynamics as a Localizing Factor for Atherosclerosis by
Cover of the book Efficiency and Equity in Welfare Economics by
Cover of the book Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs by
Cover of the book Dealing with the Fragmented International Legal Environment by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy